Amyris

Amyris Equity Growth

Delisted·May 7, 2024

The Year-over-Year Equity Growth of Amyris (AMRSQ) as of Nov 20, 2026 is -292.37 %. In the previous year, Year-over-Year Equity Growth was 246.34 % — a change of -218.69% (lower).

Equity Growth

-292.37 %

YoY

-218.69%

Last updated:

Year-over-Year Equity Growth of Amyris is 2022 -292.37 % . Year-over-Year Equity Growth of Amyris was 2021 246.34 % . It decreases by -218.69% lower compared to the previous year.

The Amyris Equity Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity Growth
Date
Equity Growth
Jan 1, 2015
-26.99 USD
Jan 1, 2016
-16.64 USD
Jan 1, 2017
-18.22 USD
Jan 1, 2018
0.09 USD
Jan 1, 2019
-15.14 USD
Jan 1, 2020
31.49 USD
Jan 1, 2021
246.34 USD
Jan 1, 2022
-292.37 USD
The Amyris Equity Growth history
YEAREquity GrowthYoY
-292.37 %-218.69%
246.34 %+682.39%
31.49 %-307.95%
-15.14 %-16,603.64%
0.09 %-100.50%
-18.22 %+9.54%
-16.64 %-38.36%
-26.99 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Amyris Stock analysis

What does Amyris do? Amyris Inc. is a US-based company specializing in the production of sustainable products. It was founded in 2003 and is headquartered in Emeryville, California. The company aims to promote sustainability in daily life and reduce dependence on fossil fuels. Amyris' business model is based on the discovery and development of biological microorganisms capable of converting sugars and other carbohydrates into valuable products such as fuels, chemicals, and flavors. This technology, known as synthetic biology, was first used for the production of artemisinin, which is used against malaria. Over time, Amyris has expanded its portfolio and specialized in the production of sustainable products for the cosmetics, biofuel, food, and chemical industries. Leading products include Biosolve, an environmentally friendly degreasing solution for the industry, Neossance, a plant-based moisturizer for the cosmetics industry, and Biofene, a bio-based fuel. To produce its products, the company has formed partnerships with various organizations around the world. For example, it has partnered with Total, a French oil and gas company, to establish joint ventures for the production of biofuels. Amyris has also expanded its business by developing a platform for synthetic biology that allows other industry players to develop custom organisms for production processes. This new business model has brought the company into new markets such as the medical and energy sectors. In 2020, the COVID-19 pandemic posed challenges for the company as demand for some products declined. In response, Amyris shifted its production to disinfectants to meet the increased demand for these products. Overall, Amyris has become a leading company in sustainable production and is committed to promoting innovations in synthetic biology to have a positive impact on the environment. Amyris is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Amyris stock

Year-over-Year Equity Growth of Amyris is -292.37 % in 2022.

On Eulerpool you can find the complete historical development of Year-over-Year Equity Growth Amyris since 2006 – with annual values, charts, and detailed analysis.

Equity growth measures the percentage change in shareholders' equity. It reflects retained earnings, share issuances, and comprehensive income effects.

To evaluate Year-over-Year Equity Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Equity Growth.

Year-over-Year Equity Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Equity Growth's Amyris historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Amyris

All Key Metrics — Amyris